US 10377772
Macrocyclic LRRK2 kinase inhibitors
granted A61PA61P25/16A61P25/28
Quick answer
US patent 10377772 (Macrocyclic LRRK2 kinase inhibitors) held by Oncodesign SA expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Oncodesign SA
- Grant date
- Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P25/16, A61P25/28, A61P43/00